JPS5740139B2 - - Google Patents

Info

Publication number
JPS5740139B2
JPS5740139B2 JP53147730A JP14773078A JPS5740139B2 JP S5740139 B2 JPS5740139 B2 JP S5740139B2 JP 53147730 A JP53147730 A JP 53147730A JP 14773078 A JP14773078 A JP 14773078A JP S5740139 B2 JPS5740139 B2 JP S5740139B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53147730A
Other languages
Japanese (ja)
Other versions
JPS5484546A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5484546A publication Critical patent/JPS5484546A/ja
Publication of JPS5740139B2 publication Critical patent/JPS5740139B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP14773078A 1977-11-30 1978-11-29 Substituted amide derivative of ll* dllphenylglycine*its manufacture and therapeutic medicine thereof Granted JPS5484546A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4997577 1977-11-30

Publications (2)

Publication Number Publication Date
JPS5484546A JPS5484546A (en) 1979-07-05
JPS5740139B2 true JPS5740139B2 (it) 1982-08-25

Family

ID=10454182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14773078A Granted JPS5484546A (en) 1977-11-30 1978-11-29 Substituted amide derivative of ll* dllphenylglycine*its manufacture and therapeutic medicine thereof

Country Status (20)

Country Link
US (1) US4218474A (it)
JP (1) JPS5484546A (it)
AR (1) AR219957A1 (it)
AT (1) AT362770B (it)
AU (1) AU507028B2 (it)
BE (1) BE872347A (it)
CA (1) CA1101846A (it)
DE (1) DE2851435C2 (it)
DK (1) DK531178A (it)
ES (1) ES475514A1 (it)
FI (1) FI783638A (it)
FR (1) FR2410644A2 (it)
IE (1) IE47635B1 (it)
IL (1) IL56064A (it)
IT (1) IT1192590B (it)
LU (1) LU80596A1 (it)
NL (1) NL7811692A (it)
PH (1) PH14681A (it)
PT (1) PT68834A (it)
SE (1) SE7812268L (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0440768B2 (it) * 1982-06-23 1992-07-06 Canon Denshi Kk

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5921656A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd ポリペプチド誘導体
US4563352A (en) * 1982-10-04 1986-01-07 The Salk Institute For Biological Studies Human pancreatic GRF
US4595677A (en) * 1982-12-03 1986-06-17 Ciba-Geigy Corporation Substituted tetrapeptides
JPS59141547A (ja) * 1983-02-01 1984-08-14 Eisai Co Ltd 鎮痛作用を有する新規ペプタイドおよび製法
GB8322414D0 (en) * 1983-08-19 1983-09-21 Szelke M Renin inhibitors
JPS61501567A (ja) * 1984-03-01 1986-07-31 ア−ク，バ−ノン 動脈硬化の予防および治療方法
EP0175714A4 (en) * 1984-03-01 1987-11-09 Vernon Erk PROCESS FOR TREATING HYPOGLYCEMIA IN VERTEBRES.
DE3587988D1 (de) * 1984-03-01 1995-03-23 Vernon Erk Behandlungsverfahren für depressionen bei wirbeltieren.
DE3586781T2 (de) * 1984-03-01 1993-05-27 Vernon Erk Behandlungsverfahren gegen hohen blutdruck bei wirbeltieren.
EP0174957A4 (en) * 1984-03-01 1987-11-09 Vernon Erk METHOD FOR THE TREATMENT OF MEMORY DISORDERS IN ELDERLY PEOPLE.
US4668663A (en) * 1984-03-27 1987-05-26 Merck & Co., Inc. Renin inhibitors containing homophe8
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
US4659693A (en) * 1984-04-30 1987-04-21 Syntex (U.S.A.) Inc. N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides
DE3527356A1 (de) * 1985-07-31 1987-02-05 Degussa Verfahren zur verbesserung der fruchtbarkeit von haustieren
US5252718A (en) * 1986-04-22 1993-10-12 The Salk Institute For Biological Studies Fibroblast growth factor antagonists
DE68922602T2 (de) * 1988-01-28 1995-12-07 Polygen Holding Corp Polypeptide mit hormonwachstumsbefreiender wirkung.
NL1010506C2 (nl) * 1998-11-06 2000-05-09 Dsm Nv Werkwijze voor de bereiding van bêta-lactam antibiotica.
KR100389644B1 (ko) * 2001-02-26 2003-06-27 한미약품 주식회사 4-히드록시페닐글리신 무수물 및 이의 제조방법
US7230097B2 (en) * 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
JP1610197S (it) 2017-09-25 2018-07-30

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868818A (en) * 1953-12-15 1959-01-13 Merck & Co Inc Alpha methyl phenylalanines
US2833764A (en) * 1954-11-18 1958-05-06 American Cyanamid Co O-methyl-l-tyrosyl amides and their preparation
US3725470A (en) * 1969-05-14 1973-04-03 Hoffmann La Roche Amino acid derivatives
ES400897A1 (es) * 1972-03-18 1975-02-01 Beecham Group Ltd Un procedimiento para la preparacion de alfa-amino-p-hidro-xibencilpenicilina o de un ester de grafito.
DE2510634A1 (de) * 1975-03-12 1976-09-23 Boehringer Mannheim Gmbh L-3-(3,4-dihydroxy-phenyl)-2- methyl-alanin-peptide und verfahren zu deren herstellung
NL7514300A (nl) * 1975-12-09 1977-06-13 Stamicarbon Werkwijze voor de bereiding van optisch actief fenylglycineamide.
US4107440A (en) * 1975-12-15 1978-08-15 Smithkline Corporation Intermediates for preparing substituted phenylglycylcephalosporins
GB1547206A (en) * 1976-09-28 1979-06-06 Pfizer Ltd Pharmaceutical compositions
PH14064A (en) * 1977-05-06 1981-01-26 Pfizer Phenylgycine derivatives,pharmaceutical compositions and method of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0440768B2 (it) * 1982-06-23 1992-07-06 Canon Denshi Kk

Also Published As

Publication number Publication date
IT1192590B (it) 1988-04-20
SE7812268L (sv) 1979-05-31
IE782359L (en) 1979-05-30
AR219957A1 (es) 1980-09-30
NL7811692A (nl) 1979-06-01
LU80596A1 (fr) 1980-06-05
IT7830290A0 (it) 1978-11-28
PH14681A (en) 1981-11-10
DE2851435A1 (de) 1979-06-13
US4218474A (en) 1980-08-19
ES475514A1 (es) 1979-04-01
AT362770B (de) 1981-06-10
PT68834A (en) 1978-12-01
CA1101846A (en) 1981-05-26
IL56064A (en) 1982-01-31
AU507028B2 (en) 1980-01-31
JPS5484546A (en) 1979-07-05
FI783638A (fi) 1979-05-31
DE2851435C2 (de) 1982-11-25
FR2410644B2 (it) 1982-10-08
AU4200878A (en) 1979-06-07
IE47635B1 (en) 1984-05-16
ATA850678A (de) 1980-11-15
IL56064A0 (en) 1979-01-31
DK531178A (da) 1979-05-31
FR2410644A2 (fr) 1979-06-29
BE872347A (fr) 1979-05-28

Similar Documents

Publication Publication Date Title
JPS5740139B2 (it)
AU3353778A (it)
DE2707092C3 (it)
AU71461S (it)
BG25852A1 (it)
BE851449A (it)
BE865722A (it)
BE866391A (it)
BE868323A (it)
BE870787A (it)
BE871419A (it)
BE871991A (it)
BE872973A (it)
BE873002A (it)
BG23438A1 (it)
BG23462A1 (it)
BG24331A1 (it)
BG24713A1 (it)
BG25808A1 (it)
BG25809A1 (it)
BG25810A1 (it)
BG25811A1 (it)
BG25812A1 (it)
BG25813A1 (it)
BG25815A1 (it)